×
About 393 results

ALLMedicine™ Eosinophilic Gastroenteritis Center

Research & Reviews  131 results

Eosinophilic Disorders of the Gastrointestinal Tract and Associated Abdominal Viscera: ...
https://doi.org/10.1148/rg.220004
Radiographics : a Review Publication of the Radiological ... Yalon M, Tahboub Amawi AD et. al.

Jun 25th, 2022 - Eosinophilic gastrointestinal disorders (EGIDs) are inflammatory conditions of the gastrointestinal tract that are characterized by tissue eosinophilia and end-organ dysfunction or damage. Primary EGIDs are associated with atopy and other allergic...

Eosinophilic diseases often overlap, raising costs
https://www.mdedge.com/internalmedicine/article/255002/gastroenterology/eosinophilic-diseases-often-overlap-raising-costs
Jim Kling

May 26th, 2022 - Eosinophilic GI diseases (EGIDs) often overlap with other eosinophil-associated diseases (EADs), which leads to greater health care costs, according to an analysis of the U. S.

A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis
https://clinicaltrials.gov/ct2/show/NCT05214768

May 17th, 2022 - The purpose of this study is to evaluate the safety and efficacy of CC-93538 in adult and adolescent participants with eosinophilic gastroenteritis.

International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomen...
https://doi.org/10.1016/j.cgh.2022.02.017
Clinical Gastroenterology and Hepatology : the Official C... Dellon ES, Gonsalves N et. al.

Feb 20th, 2022 - Substantial heterogeneity in terminology used for eosinophilic gastrointestinal diseases (EGIDs), particularly the catchall term "eosinophilic gastroenteritis," limits clinical and research advances. We aimed to achieve an international consensus ...

see more →

Clinicaltrials.gov  16 results

A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis
https://clinicaltrials.gov/ct2/show/NCT05214768

May 17th, 2022 - The purpose of this study is to evaluate the safety and efficacy of CC-93538 in adult and adolescent participants with eosinophilic gastroenteritis.

Eosinophilic Gastrointestinal Disorders Registry
https://clinicaltrials.gov/ct2/show/NCT05199532

Feb 7th, 2022 - Eosinophilic gastrointestinal disorders (EGIDs) comprise a family of disorders that includes Eosinophilic Esophagitis (EoE), Eosinophilic Gastritis (EG), Eosinophilic Gastroenteritis (EGE), and Eosinophilic Colitis (EC). The natural history of EGI...

Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
https://clinicaltrials.gov/ct2/show/NCT02897271

Sep 28th, 2021 - This retrospective chart review study will analyze the demographics, medical history, clinical features, and pathological data of patients with Eosinophilic Gastrointestinal Disorders (EGIDs) other than Eosinophilic Esophagitis (EoE) alone, includ...

A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
https://clinicaltrials.gov/ct2/show/NCT04322604

Aug 3rd, 2021 - This is a Phase 3, multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of lirentelimab (AK002), given monthly for 6 doses, in patients with moderately to severely active Eosinophilic Gastritis and/or ...

An Extension Study of Lirentelimab in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
https://clinicaltrials.gov/ct2/show/NCT04620811

Jan 7th, 2021 - This is a Phase 3, open-label, extension study to assess the long term efficacy and safety of lirentelimab given monthly.

see more →

News  9 results

Eosinophilic diseases often overlap, raising costs
https://www.mdedge.com/internalmedicine/article/255002/gastroenterology/eosinophilic-diseases-often-overlap-raising-costs
Jim Kling

May 26th, 2022 - Eosinophilic GI diseases (EGIDs) often overlap with other eosinophil-associated diseases (EADs), which leads to greater health care costs, according to an analysis of the U. S.

IBD or something else? Key characteristics offer clues
https://www.mdedge.com/internalmedicine/article/251943/gastroenterology/ibd-or-something-else-key-characteristics-offer
Nancy A. Melville

Feb 18th, 2022 - Immune-mediated inflammatory diseases (IMIDs) of the gastrointestinal (GI) tract, with features that often mimic each other, commonly present clinical challenges. But key characteristics can help distinguish the most common – inflammatory bowel di.

VIDEO: Celiac disease runs ninefold higher in eosinophilic esophagitis
https://www.mdedge.com/familymedicine/article/150051/gastroenterology/video-celiac-disease-runs-ninefold-higher
MDedge Family Medicine; Mitchel L. Zoler, PhD

Oct 23rd, 2017 - ORLANDO – Patients with eosinophilic esophagitis had a ninefold increased prevalence of celiac disease, compared with the general public, in a review of more than 35 million U. S.

Clinical Challenges - June 2017 What's Your Diagnosis?
https://www.mdedge.com/gihepnews/article/138474/clinical-challenges-june-2017-whats-your-diagnosis

May 18th, 2017 - Answer: Eosinophilic gastroenteritis Colonic (Figure D) and esophageal (Figures E and F) mucosal biopsies were obtained, which showed dense eosinophilic infiltrate of the esophageal and rectal submucosa and the rectal deep mucosa. These findings w.

A 24-Year-Old Man With Symptomatic Anemia
https://reference.medscape.com/viewarticle/876163_5

Feb 24th, 2017 - Once the diagnosis of idiopathic eosinophilic gastroenteritis has been confirmed, the mainstay of treatment is primarily oral glucocorticoids, such as prednisone, to halt the inflammatory process and control symptoms. Budesonide has also been used...

see more →

Patient Education  1 results see all →